|
|
Development
of therapeutic agents for osteoporosis and
arthritis, including nutraceutical
for the prevention of osteoporosis. |
| |
|
|
|
R&D
on bone-related
genomes |
| |
a.
Bone-specific DNA chips |
| b.
Mass screening system for bone-forming genes |
| c.
Bioactive molecules related to bone metabolism |
| |
|
|
|
Recombinant cytokines
and antibodies |
| |
|
|
|
Development of biomaterials |
| |
a. Bone substitutes |
| b.
Biomembranes |
| c.
Tissue engineering |
| |
|
|
|
Development of drug delivery
system for antibiotics and anticancer agents |
| |
|
|
|
Research services |
| |
a.
Molecular biology |
| b.
Bone cell biology |
| c.
Hard tissue biology |
| d.
Evaluation of safety and effectiveness of
medical devices |
| |
|
|
|
Development and export
of medical and dental devices |
| |
|
